In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept

Abrantes, 2009, Acute changes in obsessions and compulsions following moderate-intensity aerobic exercise among patients with obsessive-compulsive disorder, J. Anxiety Disord., 23, 923, 10.1016/j.janxdis.2009.06.008 Ahmari, 2013, Repeated cortico-striatal stimulation generates persistent OCD-like behavior, Science, 340, 1234, 10.1126/science.1234733 Behar, 1994, Analysis of macromolecule resonances in 1H NMR spectra of human brain, Magn. Reson. Med., 32, 294, 10.1002/mrm.1910320304 Bloch, 2006, A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder, Mol. Psychiatry, 11, 622, 10.1038/sj.mp.4001823 Bloch, 2012, Effects of ketamine in treatment-refractory obsessive-compulsive disorder, Biol. Psychiatry, 72, 964, 10.1016/j.biopsych.2012.05.028 Bronfeld, 2013, Motor tics evoked by striatal disinhibition in the rat, Front. Syst. Neurosci., 7, 50, 10.3389/fnsys.2013.00050 Brown, 2004, Time-domain combination of MR spectroscopy data acquired using phased-array coils, Magn. Reson. Med., 52, 1207, 10.1002/mrm.20244 Burguiere, 2013, Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors, Science, 340, 1243, 10.1126/science.1232380 Cardin, 2009, Driving fast-spiking cells induces gamma rhythm and controls sensory responses, Nature, 459, 663, 10.1038/nature08002 Chen, 2014, GABA level, gamma oscillation, and working memory performance in schizophrenia, NeuroImage Clin., 4, 531, 10.1016/j.nicl.2014.03.007 Dougherty, 2004, Pharmacotherapy for obsessive-compulsive disorder, J. Clin. Psychol., 60, 1195, 10.1002/jclp.20083 First, 1996 Geramita, 2011, Reproducibility of prefrontal gamma-aminobutyric acid measuremetns with J-edited spectroscopy, NMR Biomed., 24, 1089, 10.1002/nbm.1662 Gonzalez-Burgos, 2012, NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia, Schizophr. Bull., 38, 950, 10.1093/schbul/sbs010 Goodman, 1989, The Yale–Brown Obsessive Compulsive Scale. II. Validity, Arch. Gen. Psychiatry, 46, 1012, 10.1001/archpsyc.1989.01810110054008 Goodman, 1989, The Yale–Brown Obsessive Compulsive Scale. I. Development, use, and reliability, Arch. Gen. Psychiatry, 46, 1006, 10.1001/archpsyc.1989.01810110048007 Greenberg, 1998, Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patients, Psychopharmacology, 140, 434, 10.1007/s002130050787 Greenberg, 2000, Altered cortical excitability in obsessive-compulsive disorder, Neurology, 54, 142, 10.1212/WNL.54.1.142 Hamilton, 1960, A rating scale for depression, J. Neurol. Neurosurg. Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 Han, 2014, Enhancement of inhibitory neurotransmission by GABAA receptors having alpha2,3-subunits ameliorates behavioral deficits in a mouse model of autism, Neuron, 81, 1282, 10.1016/j.neuron.2014.01.016 Hong, 2010, Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine, Neuropsychopharmacology, 35, 632, 10.1038/npp.2009.168 Kalanithi, 2005, Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome, Proc. Natl. Acad. Sci. USA, 102, 13307, 10.1073/pnas.0502624102 Kegeles, 2013, Time course of ketamine effects on brain glutamate and GABA levels measured with 1H MRS, Schizophr. Bull., 39, S140 Kegeles, 2006, Test–retest reliability of dorsolateral prefrontal cortical GABA measuremnt using an 8-channel phased-array head cil with the J-editing technique at 3T, Proc. Int. Soc. Magn. Reson. Med., 14, 489 Kegeles, 2012, Elevated prefrontal cortex gamma-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy, Arch. Gen. Psychiatry, 69, 449, 10.1001/archgenpsychiatry.2011.1519 Kocsis, 2012, Differential role of NR2A and NR2B subunits in N-methyl-d-aspartate receptor antagonist-induced aberrant cortical gamma oscillations, Biol. Psychiatry, 71, 987, 10.1016/j.biopsych.2011.10.002 Koran, 2007, Practice guideline for the treatment of patients with obsessive-compulsive disorder, Am. J. Psychiatry, 164, 5 Maia, 2008, The neural bases of obsessive-compulsive disorder in children and adults, Dev. Psychopathol., 20, 1251, 10.1017/S0954579408000606 Markwardt, 2009, Non-linear least squares fitting in IDL with MPFIT, Proc. Astron. Data Anal. Softw. Syst., 411, 251 Marshall, 2000, Choice of spectroscopic lineshape model affects metabolite peak areas and area ratios, Magn. Reson. Med., 44, 646, 10.1002/1522-2594(200010)44:4<646::AID-MRM20>3.0.CO;2-0 McNally, 2011, Complex receptor mediation of acute ketamine application on in vitro gamma oscillations in mouse prefrontal cortex: modeling gamma band oscillation abnormalities in schizophrenia, Neuroscience, 199, 51, 10.1016/j.neuroscience.2011.10.015 Milak, 2015, A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder, Mol. Psychiatry Mullins, 2014, Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA, NeuroImage, 86, 43, 10.1016/j.neuroimage.2012.12.004 Murphy, 1989, Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers, Psychopharmacology, 98, 275, 10.1007/BF00444705 Pigott, 1999, A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder, J. Clin. Psychiatry, 60, 101, 10.4088/JCP.v60n0206 Pinto, 2008, Further development of YBOCS dimensions in the OCD Collaborative Genetics study: symptoms vs. categories, Psychiatry Res., 160, 83, 10.1016/j.psychres.2007.07.010 Pinto, 2009, Using individual items to clarify OCD symptom structure: the case for five factors, Am. J. Psychiatry, 166, 728, 10.1176/appi.ajp.2009.09020287 Pittenger, 2011, Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment, Pharmacol. Ther., 132, 314, 10.1016/j.pharmthera.2011.09.006 Pogorelov, 2015, Corticostriatal interactions in the generation of tic-like behaviors after local striatal disinhibition, Exp. Neurol., 265, 122, 10.1016/j.expneurol.2015.01.001 Richter, 2012, Evidence for cortical inhibitory and excitatory dysfunction in obsessive compulsive disorder, Neuropsychopharmacology, 37, 1144, 10.1038/npp.2011.300 Rodriguez, 2011, Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorder, J. Clin. Psychiatry, 72, 567, 10.4088/JCP.10l06653 Rodriguez, 2013, Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept, Neuropsychopharmacology, 38, 2475, 10.1038/npp.2013.150 Rosenberg, 2000, Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine, J. Am. Acad. Child Adolesc. Psychiatry, 39, 1096, 10.1097/00004583-200009000-00008 Rosenberg, 2004, Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls, J. Am. Acad. Child Adolesc. Psychiatry, 43, 1146, 10.1097/01.chi.0000132812.44664.2d Rothman, 1993, Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo, Proc. Natl. Acad. Sci. USA, 90, 5662, 10.1073/pnas.90.12.5662 Rowland, 2005, Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study, Am. J. Psychiatry, 162, 394, 10.1176/appi.ajp.162.2.394 Shungu, D.C., 2013. Demystifying the “Glx” peak that co-edits with GABA by J-editing, in: Proceedings of the 2nd Cardiff International Symposium on MRS of GABA. Cardiff, Wales, UK. Shungu, 2013, ‘Glx’ measured by J-editing/MEGA-PRESS is primarily ‘pure’ glutamate…or is it?, Proc. Int. Soc. Magn. Reson. Med., 21, 3985 Simpson, 2012, Investigation of cortical glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy, Neuropsychopharmacology, 37, 2684, 10.1038/npp.2012.132 Starck, 2008, A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity, J. Neural Transm., 115, 1051, 10.1007/s00702-008-0045-4 Stone, 2012, Ketamine effects on brain GABA and glutamate levels with 1H MRS: relationship to ketamine-induced psychopathology, Mol. Psychiatry, 17, 664, 10.1038/mp.2011.171 Taylor, 2012, Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study, J. Psychopharmacol., 26, 733, 10.1177/0269881111405359 Valentine, 2011, The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS, Psychiatry Res. Neuroimaging, 191, 122, 10.1016/j.pscychresns.2010.10.009 Vinck, 2013, Attentional modulation of cell-class-specific gamma-band synchronization in awake monkey area v4, Neuron, 80, 1077, 10.1016/j.neuron.2013.08.019 Whittington, 2000, Inhibition-based rhythms: experimental and mathematical observations on network dynamics, Int. J. Psychophysiol., 38, 315, 10.1016/S0167-8760(00)00173-2 Yucel, 2008, Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder, Aust. N. Z. J. Psychiatry, 42, 467, 10.1080/00048670802050546 Zai, 2005, Evidence for the gamma-amino-butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive-compulsive disorder, Am. J. Med. Genet. B Neuropsychiatr. Genet., 134B, 25, 10.1002/ajmg.b.30152 Zai, 2005, Possible association between the gamma-aminobutyric acid type B receptor 1 (GABBR1) gene and schizophrenia, Eur. Neuropsychopharmacol., 15, 347, 10.1016/j.euroneuro.2004.12.006